●February 22, 2010: In the Nihon Keizai Shimbun 2010 annual survey for the 100 most desirable companies to work conducted among the future graduates from major universities nation-wide the only pharmaceutical company - Takeda Yakuhin Kogyo KK ranks at 66th place (down from 48th in 2009) ... Takeda products in JAD Databases
●February 12, 2010: JKS News: The price at Tokyo Stock Exchange (TSE) of SS Seiyaku KK gained 20% after Boehringer Ingelheim GmbH / Nippon Boehringer Ingelheim KK launched a tender offer for all outstanding shares of third largest OTC / generic maker in Japan ... products details in JAD Databases
●February 1, 2010: JKS News: PMDA updates the comprehensive information on quasi-drug regulations, including the draft requirements for the raw ingredients ... OTC, BTC and quasi-drug consulting services
●January 25, 2010: Diabetes news: Banyu Seiyaku KK , a Merck &C. group company buoyed by the prospects for the first-of-class DPP-4 (dipeptidyl peptidase IV) inhibitor Januvia (sitagliptin) in the diabetes market in Japan, projected to grow by 50% by 2017 to 377 billion Yen ... Anti-diabetes products in JAD Databases | Metabolic Syndrome report preview | Epidemiology of diabetes data
●January 21, 2010: Flu pandemic in Japan update (8) - vaccine glut: The MHLW approved the use, but may cancel part of the purchase contract for 9.9 million doses of foreign-made anti-H1N1 vaccines (7.4 million doses of Pandemrix and 2.5 million doses of Celtura) after only one prefecture in Japan requested just 200 doses of products imported by the domestic subsidiaries of by Britain's GlaxoSmithKline PLC and Switzerland's Novartis AG ; the distribution of the imported vaccines - made by using cell cultures and containing no unapproved adjuvant (MF59) to start in February as 10,000-subject PMS is scheduled to offset the limitation of emergency 100-subject pre-approval trial; the National Institute of Infectious Diseases (NIID) estimated the number of infected to have reached 19.23 millions ... Anti-flu products in JAD Databases | Epidemiology consulting and data
●January 3, 2010: Generics News: The JV company Teva-Kowa Pharma KK to launch on 5th of January, 37 new generics - first batch of scheduled nearly 300 products ... Generics in JAD Databases | Generics report preview
●January 13, 2010: Flu pandemic in Japan update (7): Shionogi Seiyaku KK granted Marketing and Manufacturing Approval for two formulations of Rapiacta (Peramivir): 300 mg bag for i.v. drip infusion and 15 mg vial for i.v. drip infusion, developed in Japan under license from BioCryst Pharmaceuticals, Inc. for treatment of infections with influenza A and B virus strains after a record short development period including Phase III multi-national (Japan, Taiwan, S. Korea) study and submission in November 2009; nation-wide epidemiological study led by the Japan Science and Technology Agency (JST) found that those aged over 6o are far less susceptible to the new influenza due to previous epidemics in 1940s ... Anti-flu products in JAD Databases | Epidemiology consulting and data
●January 8, 2010: JKS News: In a move toward streamlining health insurance schemes, the MHLW revealed premium disparity among the 3,500 public medical insurance programs, including the 1,474 corporate health insurance associations and Japan Health Insurance Association (Kyokai Kempo); announced a bid to curb the subsidies paid to insurance associations of self-employed (physicians, construction laborers) - widely believed to be vote-gathering centers ... Pricing & Reimbursement consulting

Archived headline news from other periods could be found here:

• News 2006 - 2010

The JAD News Database is currently in beta-testing and expected to be launched in 2010 for all registered users